Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice

Running, not enrolling

Conditions studied: Lung Cancer, Lung; Nodule

In brief

A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.

Key facts

Study ID

NCT06685133

Run by

Noah Medical

People needed

50

Starts

2024-11-08

Expected to finish

2027-10-30

Last updated by the study team

2025-08-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18
• Patients with indeterminate lung nodule
• Peripheral pulmonary subsolid and solid nodules (PPNs) sized up to 3 cm measured as the largest dimension based on the pre-procedural CT
• Pre-procedural CT is conducted within 90 days of the bronchoscopy procedure
• Informed consent properly obtained per local regulations

You may not qualify if…

• Known pregnancy or breastfeeding
• Patients with pure ground-glass nodules on pre-procedural chest CT
• Uncontrolled coagulopathy or bleeding disorders
• Ongoing systemic infection
• History of lobectomy or pneumonectomy
• Patients with pacemakers or defibrillators
• Unsuitable for bronchoscopy procedure under general anesthesia as agreed by the treating clinician and anesthetist
• Patients with pleural effusion or diaphragmatic paralysis

Where it is running

• CHI Memorial Hospital — Chattanooga, Tennessee, United States
• Inova Fairfax Medical Campus — Falls Church, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.